Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk: an FNIH-ASBMR SABRE study pooled analysis.-MedSci.cn

Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk: an FNIH-ASBMR SABRE study pooled analysis.

Bouxsein, M; Vittinghoff, E; Lui, LY; Ewing, S; Schwartz, A; Bauer, D; Black, D; Eastell, R

JOURNAL OF BONE AND MINERAL RESEARCH, 2022; 37 (): 352

科室
- - 订阅+
  - 更多科室
工具
服务